Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
tolerability
Description:
The degree to which a patient can endure a treatment's adverse effects, assessed in clinical studies of medicines and therapies.
Wikidata ID:
wiki/Q7814214
OpenAlex ID:
keywords/tolerability
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
2005
·
B. Miletzki
, C. H. Gleiter
·
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
·
9,401
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013
·
Stefan Leucht
, Andrea Cipriani
, et al.
·
The Lancet
·
2,716
Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial
2007
·
John P. O’Reardon
, H. Brent Solvason
, et al.
·
Biological Psychiatry
·
1,981
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
2010
·
Andrew Tutt
, Mark Robson
, et al.
·
The Lancet
·
1,709
Noncoding RNA therapeutics — challenges and potential solutions
2021
·
Melanie Winkle
, Sherien M. El-Daly
, et al.
·
Nature Reviews Drug Discovery
·
1,640
PDF
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
2020
·
Mark J. Mulligan
, Kirsten E. Lyke
, et al.
·
Nature
·
1,604
PDF
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis
2018
·
Samuele Cortese
, Nicoletta Adamo
, et al.
·
The Lancet Psychiatry
·
1,556
PDF
A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation
2011
·
Andre Russowsky Brunoni
, Joao Amadera
, et al.
·
The International Journal of Neuropsychopharmacology
·
1,298
PDF
Tolvaptan, a Selective Oral Vasopressin V 2 -Receptor Antagonist, for Hyponatremia
2006
·
Robert W. Schrier
, Peter Gross
, et al.
·
New England Journal of Medicine
·
1,227
PDF
Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease
2006
·
Lon S. Schneider
, Pierre N. Tariot
, et al.
·
New England Journal of Medicine
·
1,220
PDF
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
2009
·
Arne Astrup
, Stephan Rössner
, et al.
·
The Lancet
·
1,195
Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
2011
·
Kishore M Gadde
, David B Allison
, et al.
·
The Lancet
·
1,095
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
2017
·
R. L. Carhart-Harris
, M. Bolstridge
, et al.
·
Psychopharmacology
·
1,068
PDF
Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines
2019
·
Kimberly J. Hassett
, Kerry E. Benenato
, et al.
·
Molecular Therapy — Nucleic Acids
·
943
PDF
A 5-month, randomized, placebo-controlled trial of galantamine in AD
2000
·
P.N. Tariot
, P.R. Solomon
, et al.
·
Neurology
·
926
Ferrous Sulfate Supplementation Causes Significant Gastrointestinal Side-Effects in Adults: A Systematic Review and Meta-Analysis
2015
·
Zoe Tolkien
, Lynne Stecher
, et al.
·
PLoS ONE
·
896
PDF
The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects
2007
·
Joachim Stangier
, Karin Rathgen
, et al.
·
British Journal of Clinical Pharmacology
·
892
Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure: Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study: The RESOLVD Pilot Study Investigators
1999
·
R. S. McKelvie
, S. Yusuf
, et al.
·
Circulation
·
884
PDF
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer
2019
·
M.E. Robson
, N. Tung
, et al.
·
Annals of Oncology
·
835
Hoe 140 a new potent and long acting bradykinin‐antagonist:in vivostudies
1991
·
K. Wirth
, F.J. Hock
, et al.
·
British Journal of Pharmacology
·
828
PDF
Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placebo
1997
·
Lisa A. Arvanitis
, Barbara G. Miller
·
Biological Psychiatry
·
802
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
2003
·
Paul J. Hesketh
, Steven M. Grunberg
, et al.
·
Journal of Clinical Oncology
·
779
ZD1839, a Selective Oral Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor, Is Well Tolerated and Active in Patients With Solid, Malignant Tumors: Results of a Phase I Trial
2002
·
Malcolm Ranson
, Lisa A. Hammond
, et al.
·
Journal of Clinical Oncology
·
772
ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study
2006
·
Yvonne Freund-Levi
, Maria Eriksdotter-Jönhagen
, et al.
·
Archives of Neurology
·
771
Opioid antagonists for alcohol dependence
2002
·
M Srisurapanont
, N Jarusuraisin
·
Cochrane Database of Systematic Reviews
·
763
Show more works
View as search
Works count:
33,640
Citation count:
734,500
Year
Topic
Type